Botanical species · safety record

Senna alata

The EFSA Compendium of Botanicals holds 20 constituent measurements, 4 adverse-effect records and 1 genotoxicity assay for Senna alata. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Senna alata (L.) Roxb.

20Constituent measurements
5Safety records
11Cited sources
3Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 3 licensed products naming Senna alata as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

  • Leaf

What the records describe

Constituents measured

  • Saponins3
  • Tannins3
  • Alkaloids2
  • Anthraquinone2
  • Sennoside a2
  • 1,8-cineole1
  • Cardiac glycosides1
  • Chrysophanol1
  • Emodin1
  • Isoflavones1

Plant parts

  • Leaves19
  • Roots and other underground parts4
  • Live plants1

Preparations

  • Solvent extraction23
  • Essential oil1

Effect types

  • Nephrotoxicity2
  • Reproductive2

Target tissues

  • Urogenital: kidneys2
  • Uterus2

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
AlkaloidsLeavesSolvent extraction0.52 PercentPhytochemical screeningResolve DOI
SaponinsLeavesSolvent extraction1.22 PercentPhytochemical screeningResolve DOI
1,8-cineoleLeavesEssential oil39.8 PercentGC-MSNo resolvable identifier
AlkaloidsLeavesSolvent extraction4.36 PercentPhytochemical screeningNo resolvable identifier
AnthraquinoneLeavesSolvent extractionPhytochemical screeningNo resolvable identifier
AnthraquinoneLeavesSolvent extractionPhytochemical screeningNo resolvable identifier
Cardiac glycosidesLeavesSolvent extractionPhytochemical screeningNo resolvable identifier
ChrysophanolRoots and other underground partsSolvent extraction21.6 ppmGelpermeation, High Performance Thin Layer Chromatography (HPTLC)No resolvable identifier
EmodinRoots and other underground partsSolvent extraction26.5 ppmGelpermeation, High Performance Thin Layer Chromatography (HPTLC)No resolvable identifier
IsoflavonesLeavesSolvent extractionNuclear Magnetic Resonance (NMR)No resolvable identifier
PhyscionRoots and other underground partsSolvent extraction4.45 ppmGelpermeation, High Performance Thin Layer Chromatography (HPTLC)No resolvable identifier
RheinRoots and other underground partsSolvent extraction68.4 ppmGelpermeation, High Performance Thin Layer Chromatography (HPTLC)No resolvable identifier
SaponinsLeavesSolvent extraction2.41 PercentPhytochemical screeningNo resolvable identifier
SaponinsLeavesSolvent extractionPhytochemical screeningNo resolvable identifier
Sennoside aLive plantsSolvent extraction2.34 Milligram/gramEnzyme-linked immunosorbent assay (ELISA)No resolvable identifier
Sennoside aLeavesSolvent extraction0.119 Microgram/gramStandard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier
Sennoside bLeavesSolvent extraction0.116 Microgram/gramStandard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier
TanninsLeavesSolvent extractionPhytochemical screeningNo resolvable identifier
TanninsLeavesSolvent extractionPhytochemical screeningNo resolvable identifier
TanninsLeavesSolvent extractionPhytochemical screeningNo resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
ReproductiveUterusLeavesSolvent extractionRat (as animal)Reproduction toxicityResolve DOI
ReproductiveUterusLeavesSolvent extractionRat (as animal)Reproduction toxicityResolve DOI
NephrotoxicityUrogenital: kidneysLeavesSolvent extractionRat (as animal)Short-term toxicityNo resolvable identifier
NephrotoxicityUrogenital: kidneysLeavesSolvent extractionRat (as animal)Short-term toxicityNo resolvable identifier

Genotoxicity testing

Outcomes of genotoxicity assays as recorded in the source. A negative assay is a result under those test conditions, not a clearance.

OutcomeEndpointTestTested organismMetabolic activationSource
Positivebacterial reverse mutation assayEscherichia coli (as organism)With and withoutResolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Veerachari, U., Bopaiah, A.K. Phytochemical investigation of the ethanol, methanol and ethyl acetate leaf extracts of six cassia species. International Journal of Pharma and Bio Sciences, 2012, vol. 3, no. 2, p. P260-P270.
  2. Ogunkunle, A. T. J., Ladejobi, Tonia A. Ethnobotanical and phytochemical studies on some species of Senna in Nigeria. AFRICAN JOURNAL OF BIOTECHNOLOGY, 2006, vol. 5, no. 21, p. 2020-2023.
  3. Abii, T. A., Onuha, E. N. A preliminary investigation into the phytochemicals, vitamins and mineral constituents of the leaf of two tradomedicinal plants - urena lobata and cassia alata used in Nigeria. IOSR Journal of Applied Chemistry, 2014, p. 1-4.
  4. MT, Y., AO, A., AT, O., MA, A., OB, O., GA, J., AWO, O., AJ, A. Abortifacient Potential of Aqueous Extract of Senna alata Leaves in Rats. Journal of Reproduction and Contraception, 2010, vol. 21, no. 3, p. 163-177. DOI
  5. Rahman, M. S., Hasan, A. J. M. Moynul., Ali, M. Y., Ali, M. U. An isoflavone from the leaves of Cassia alata. Bangladesh journal of scientific and industrial research, 2005, p. 287-290.
  6. Fernand, Vivian E., Dinh, David T., Washington, Samuel J., Fakayode, Sayo O., Losso, Jack N., van Ravenswaay, Rick O., Warner, Isiah M. Determination of pharmacologically active compounds in root extracts of Cassia alata L. by use of high performance liquid chromatography. Talanta, 2008, p. 896-902.
  7. Yakubu, Musa Toyin., Musa, Isah Fakai. Liver and kidney functional indices of pregnant rats following the administration of the crude alkaloids from Senna alata (Linn. Roxb) leaves. Iranian Journal of Toxicology, 2012, p. 615-625.
  8. Hong, Chang-Eui., Lyu, Su-Yun. Genotoxicity detection of five medicinal plants in Nigeria. JOURNAL OF TOXICOLOGICAL SCIENCES, 2011, vol. 36, no. 1, p. 87-93. DOI
  9. Ogunwande, I.A., Flamini, G., Cioni, P.L., Omikorede, O., Azeez, R.A., Ayodele, A.A., Kamil, Y.O. Aromatic plants growing in Nigeria: Essential oil constituents of Cassia alata (Linn.) Roxb. and Helianthus annuus L. Records of natural products, 2010, vol. 4, no. 4, p. 211-217.
  10. Morinaga, Osamu., Uto, Takuhiro., Sakamoto, Seiichi., Putalun, Waraporn., Lhieochaiphant, Sorasak., Tanaka, Hiroyuki., Shoyama, Yukihiro. Development of eastern blotting technique for sennoside A and sennoside B using anti-sennoside A and anti-sennoside B monoclonal antibodies. Phytochemical Analysis, 2009, p. 154-158.
  11. Morinaga, Osamu., Uto, Takuhiro., Sakamoto, Seiichi., Tanaka, Hiroyuki., Shoyama, Yukihiro. Enzyme-linked immunosorbent assay for total sennosides using anti-sennoside A and anti-sennoside B monoclonal antibodies. Fitoterapia, 2009, p. 28-31.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue